Benzo(d)thiazol-2-amine → 3-(3-Methoxy-propyl)-3H-benzothiazol-2-ylideneamine hydrobromide
Reaction equation
[S:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[NH2:10].[Br:11][CH2:12][CH2:13][CH2:14][O:15][CH3:16]>>[BrH:11].[CH3:16][O:15][CH2:14][CH2:13][CH2:12][N:3]1[C:4]2[CH:9]=[CH:8][CH:7]=[CH:6][C:5]=2[S:1][C:2]1=[NH:10]Participants
3
Procedure
Benzothiazol-2-ylamine (1.0 g, 6.6 mmol) and 1-bromo-3-methoxy-propane (1.2 g, 7.9 mmol) were processed as described in Example 2A. Recrystallization from ethyl acetate afforded 1.7 g (89%) of the title compound. 1H NMR (DMSO-d6, 300 MHz) δ ppm 1.90-2.02 (m, 2H), 3.18 (s, 3H), 3.39 (t, J=5.9 Hz, 2H), 4.31 (t, J=7.1 Hz, 2H), 7.37-7.48 (m, 1H), 7.53-7.69 (m, 2H), 8.00 (dd, J=8.0, 0.8 Hz, 1H), 10.08 (s, 1H); MS (DCI/NH3) m/z 233 (M+H)+.
Workup
- customRecrystallization from ethyl acetate
Sources & evidence
- ORD record
- ord-b76595be0ba2450d9628119072a82bf6
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09006275B2
Reaction notes
Loading…